NCT00177372View on ClinicalTrials.gov

Mifepristone and Misoprostol for Fetal Demise

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Anembryonic PregnancyGestation AbnormalityIntrauterine Fetal Demise Term
Interventions
DRUG

mifepristone/misoprostol

mifepristone 200 mg followed 24 hours later by misoprostol 800 mcg vaginally

Trial Locations (1)

15213

Magee-Womens Hospital, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT00177372 - Mifepristone and Misoprostol for Fetal Demise | Biotech Hunter | Biotech Hunter